Go Back
New Era Capital Partners
New Era Capital Partners, founded in 2018, is a venture fund based in Tel Aviv, Israel, focusing on Seed to Series D investments in BioTech, Healthcare, Information Technology, and Life Science sectors. With Gideon Argov as a partner, the firm has invested in 20 companies and has had 1 exit. Portfolio companies include Variantyx. New Era Capital Partners seeks to support technology-focused global enterprises. For more information, visit their website at www.neweracp.com or reach out to Gideon Argov via email at gideon@neweracp.com.
About
About
About
Bio
New Era Capital Partners is a venture capital firm that invests in technology-focused and global enterprises.
Location
Tel Aviv, Israel
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Gideon Argov
Bio
New Era Capital Partners is a venture capital firm that invests in technology-focused and global enterprises.
Location
Tel Aviv, Israel
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Gideon Argov
Fund
Fund
Fund
Fund Focus
BioTech, Healthcare, Information Technology, Life Science
Number of investments
20
Number of exits
1
Fund Type
Venture Fund
Portfolio Companies
Variantyx
New Era Capital Partners
New Era Capital Partners, founded in 2018, is a venture fund based in Tel Aviv, Israel, focusing on Seed to Series D investments in BioTech, Healthcare, Information Technology, and Life Science sectors. With Gideon Argov as a partner, the firm has invested in 20 companies and has had 1 exit. Portfolio companies include Variantyx. New Era Capital Partners seeks to support technology-focused global enterprises. For more information, visit their website at www.neweracp.com or reach out to Gideon Argov via email at gideon@neweracp.com.
About
Bio
New Era Capital Partners is a venture capital firm that invests in technology-focused and global enterprises.
Location
Tel Aviv, Israel
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Gideon Argov
Fund
Fund Focus
BioTech, Healthcare, Information Technology, Life Science
Number of investments
20
Number of exits
1
Fund Type
Venture Fund
Portfolio Companies
Variantyx